Bisoprolol Fumarate And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 59651-679

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 59651-679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Bisoprolol Fig1)

Packaging label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg strength, oral film-coated tablets. The label indicates 30 tablets per unit-of-use container, labeled Rx only, distributed by Aurobindo Pharma USA, Inc., with storage and dispensing instructions. The product is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Fig (Bisoprolol Fig2)

Label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 5 mg/6.25 mg, film-coated tablets, oral use. The label states a 30-tablet unit-of-use package, Rx only, distributed by Aurobindo Pharma USA, Inc. It includes storage instructions and notes on packaging container requirements. Made in India with a printed barcode and a designated coding area.*

FDA Label Image

Fig (Bisoprolol Fig3)

Label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 10 mg/6.25 mg, film-coated oral tablets. The label indicates a package size of 30 tablets, unit-of-use, distributed by Aurobindo Pharma USA, Inc., made in India. It includes storage instructions and dosage note, with a barcode on the right side.*

FDA Label Image

Str (Bisoprolol Str1)

Chemical structure of Bisoprolol Fumarate, showing the molecular arrangement including aromatic rings, ether linkages, and fumarate acid moiety.*

FDA Label Image

Str (Bisoprolol Str2)

Chemical structure diagram of Bisoprolol Fumarate and Hydrochlorothiazide, showing the molecular arrangement including rings, chlorine atom, sulfonamide, and other functional groups relevant to this active ingredient combination.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.